Question reference: S4W-27018
- Asked by: Nanette Milne, MSP for North East Scotland, Scottish Conservative and Unionist Party
- Date lodged: 7 August 2015
-
Current status: Answered by Shona Robison on 4 September 2015
Question
To ask the Scottish Government what assessment it has made of how the Scottish Medicines Consortium takes account of recommendations from Patient and Clinician Engagement groups in its final decisions.
Answer
The Scottish Medicines Consortium (SMC) developed the Patient and Clinician Engagement (PACE) process with input from stakeholders. The Scottish Government’s position remains that the views of those involved in PACE should be a determining factor in decisions made. The Scottish Government has previously stated that there will be a formal review of the new SMC approach in 2015-16 and that we are open to considering any further changes. The Scottish Government is currently working with the SMC on the remit of the review which will be shared with stakeholders prior to publication.